Interaction between gut microbiota and immune checkpoint inhibitor-related colitis

Immune checkpoint inhibitors (ICIs) have become a promising therapeutic strategy for malignant tumors, improving patient prognosis, along with a spectrum of immune-related adverse events (irAEs), including gastrointestinal toxicity, ICI-related colitis (IRC), and diarrhea. The gut microbiota has bee...

Full description

Bibliographic Details
Main Authors: Guanzhou Zhou, Nana Zhang, Ke Meng, Fei Pan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1001623/full
_version_ 1811336102073597952
author Guanzhou Zhou
Guanzhou Zhou
Nana Zhang
Nana Zhang
Ke Meng
Fei Pan
author_facet Guanzhou Zhou
Guanzhou Zhou
Nana Zhang
Nana Zhang
Ke Meng
Fei Pan
author_sort Guanzhou Zhou
collection DOAJ
description Immune checkpoint inhibitors (ICIs) have become a promising therapeutic strategy for malignant tumors, improving patient prognosis, along with a spectrum of immune-related adverse events (irAEs), including gastrointestinal toxicity, ICI-related colitis (IRC), and diarrhea. The gut microbiota has been suggested as an important regulator in the pathogenesis of IRC, and microbiota modulations like probiotics and fecal microbiota transplantation have been explored to treat the disease. This review discusses the interaction between the gut microbiota and IRC, focusing on the potential pathogenic mechanisms and promising interventions.
first_indexed 2024-04-13T17:33:38Z
format Article
id doaj.art-c9160c1d24454a4dbc40b7a382b1dd2d
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-13T17:33:38Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-c9160c1d24454a4dbc40b7a382b1dd2d2022-12-22T02:37:28ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-10-011310.3389/fimmu.2022.10016231001623Interaction between gut microbiota and immune checkpoint inhibitor-related colitisGuanzhou Zhou0Guanzhou Zhou1Nana Zhang2Nana Zhang3Ke Meng4Fei Pan5Department of Gastroenterology and Hepatology, The First Medical Center, Chinese PLA General Hospital, Beijing, ChinaSchool of Medicine, Nankai University, Tianjin, ChinaDepartment of Gastroenterology and Hepatology, The First Medical Center, Chinese PLA General Hospital, Beijing, ChinaMedical School of Chinese PLA, Beijing, ChinaDepartment of Gastroenterology and Hepatology, The First Medical Center, Chinese PLA General Hospital, Beijing, ChinaDepartment of Gastroenterology and Hepatology, The First Medical Center, Chinese PLA General Hospital, Beijing, ChinaImmune checkpoint inhibitors (ICIs) have become a promising therapeutic strategy for malignant tumors, improving patient prognosis, along with a spectrum of immune-related adverse events (irAEs), including gastrointestinal toxicity, ICI-related colitis (IRC), and diarrhea. The gut microbiota has been suggested as an important regulator in the pathogenesis of IRC, and microbiota modulations like probiotics and fecal microbiota transplantation have been explored to treat the disease. This review discusses the interaction between the gut microbiota and IRC, focusing on the potential pathogenic mechanisms and promising interventions. https://www.frontiersin.org/articles/10.3389/fimmu.2022.1001623/fullimmune checkpoint inhibitorgut microbiotacolitisdiarrheamicrobiome
spellingShingle Guanzhou Zhou
Guanzhou Zhou
Nana Zhang
Nana Zhang
Ke Meng
Fei Pan
Interaction between gut microbiota and immune checkpoint inhibitor-related colitis
Frontiers in Immunology
immune checkpoint inhibitor
gut microbiota
colitis
diarrhea
microbiome
title Interaction between gut microbiota and immune checkpoint inhibitor-related colitis
title_full Interaction between gut microbiota and immune checkpoint inhibitor-related colitis
title_fullStr Interaction between gut microbiota and immune checkpoint inhibitor-related colitis
title_full_unstemmed Interaction between gut microbiota and immune checkpoint inhibitor-related colitis
title_short Interaction between gut microbiota and immune checkpoint inhibitor-related colitis
title_sort interaction between gut microbiota and immune checkpoint inhibitor related colitis
topic immune checkpoint inhibitor
gut microbiota
colitis
diarrhea
microbiome
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.1001623/full
work_keys_str_mv AT guanzhouzhou interactionbetweengutmicrobiotaandimmunecheckpointinhibitorrelatedcolitis
AT guanzhouzhou interactionbetweengutmicrobiotaandimmunecheckpointinhibitorrelatedcolitis
AT nanazhang interactionbetweengutmicrobiotaandimmunecheckpointinhibitorrelatedcolitis
AT nanazhang interactionbetweengutmicrobiotaandimmunecheckpointinhibitorrelatedcolitis
AT kemeng interactionbetweengutmicrobiotaandimmunecheckpointinhibitorrelatedcolitis
AT feipan interactionbetweengutmicrobiotaandimmunecheckpointinhibitorrelatedcolitis